Paper Details

  1. Home
  2. Paper Details

Lessons from ONTARGET.

Author: BerlaimontV, BilliouwJ-M, BrohetC, DupontA G, GazagnesM-D, HellerF, HermanA G, KrzesinskiJ M, MissaultL, PersuA, PiérardL, RottiersR, Van MieghemW, VanhoorenG, VervaetP

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Telmisartan was as effective as ramipril in preventing cardiovascular events in patients at high risk.
Paper Details　
Original Abstract of the Article :
The recently published results of the ONTARGET trial shed a new light on the cardiovascular protection of patients at high risk of a cardiovascular event. Despite a number of trials looking at the efficacy of Angiotensin Converting Enzyme inhibitors (ACEis) or Angiotensin Receptor Blockers (ARBs) in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1179/acb.2008.025

データ提供：米国国立医学図書館（NLM）

Heart Health: Navigating the Desert of Cardiovascular Risk

Cardiovascular disease is a major concern for many people, and finding effective ways to prevent heart attacks and strokes is crucial. This study focuses on the ONTARGET trial, which investigated the effectiveness of different medications for preventing cardiovascular events in high-risk patients. It's like exploring a vast desert, where understanding the terrain and choosing the right path can make all the difference in reaching your destination.

ONTARGET: Guiding Us Towards Heart Health

The ONTARGET trial provides valuable insights into the effectiveness of different medications for preventing cardiovascular events. It shows that telmisartan and ramipril are both effective, but telmisartan appears to be better tolerated. The study also found that combining these medications does not necessarily lead to better outcomes. These findings are important for guiding treatment decisions and ensuring optimal patient care.

Cardiovascular Health: It's a Journey, Not a Destination

This study highlights the complexity of cardiovascular health. There's no one-size-fits-all approach, and finding the right medications and lifestyle choices for each individual is crucial. It's a journey that requires careful monitoring and adjustments along the way.

Dr.Camel's Conclusion

Just as a camel must navigate the diverse landscapes of the desert, we must carefully consider the different pathways to cardiovascular health. This study provides valuable insights into the effectiveness of different medications and the importance of tailoring treatment plans to individual needs.

Date :
  1. Date Completed 2008-09-23
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

18714845

DOI: Digital Object Identifier

10.1179/acb.2008.025

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.